APA (7th ed.) Citation

Kucherenko, A., Pampukha, V., Bobrova, I., Moroz, L., & Livshits, L. (2015). ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C.

Chicago Style (17th ed.) Citation

Kucherenko, A., V. Pampukha, I. Bobrova, L. Moroz, and L. Livshits. ITPA Gene Variant May Protect Against Anemia Induced During Pegylated Interferon Alfa and Ribavirin Combination Treatment in Ukrainian Patients with Chronic Hepatitis C. 2015.

MLA (8th ed.) Citation

Kucherenko, A., et al. ITPA Gene Variant May Protect Against Anemia Induced During Pegylated Interferon Alfa and Ribavirin Combination Treatment in Ukrainian Patients with Chronic Hepatitis C. 2015.

Warning: These citations may not always be 100% accurate.